NCT07636005

Brief Summary

The goal of this clinical trial is to prevent postpartum depression in pregnant women. The main questions it aims to answer are:

  • receive 5 sessions in 3 weeks ( 2 sessions per week)
  • get follow-up at 2 weeks and 6 weeks after delivery

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Mar 2026Aug 2026

Study Start

First participant enrolled

March 10, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 9, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2026

Expected
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2026

Last Updated

June 9, 2026

Status Verified

June 1, 2026

Enrollment Period

6 months

First QC Date

May 28, 2026

Last Update Submit

June 4, 2026

Conditions

Keywords

Postpartum depressionpsychological empowerment

Outcome Measures

Primary Outcomes (1)

  • Postpartum Depression

    Postpartum Depression Symptoms (EPDS) The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire used to assess depressive symptoms during the perinatal period. Each item is scored on a 4-point scale (0-3), with total scores ranging from 0 to 30. Higher scores indicate more severe depressive symptoms. A score of 13 or higher is considered indicative of probable postpartum depression and suggests the need for further psychological assessment. Lower scores represent better mental health outcomes and fewer depressive symptoms.

    - From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)

Secondary Outcomes (3)

  • Perceived Control

    - From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)

  • Self Efficacy

    - From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)

  • Coping Behavior

    - From enrollment to the end of the intervention will take 3 weeks (during pregnancy, participants' gestation age in the range 35-38 weeks) - Follow-up 1: at 2 weeks after delivery - Follow-up 2: at 6 weeks after delivery (each participant may vary)

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants assigned to the intervention group will receive the Psychological Empowerment Program in addition to routine care. A total of 46 pregnant women will be divided into four groups based on their time convenience, with each group consisting of 10-12 women. It would be beneficial to increase intervention fidelity and make it easier for the researcher to follow up at the time, as well as provide opportunities for more interactions within the peer group. Each group will receive the intervention at a different time. The program consists of structured 5 sessions in 3 weekly sessions (2 sessions in one week). Sessions include psychoeducation, guided discussions, emotional coping exercises, communication and conflict resolution training, problem-solving activities, and practical parenting preparation The intervention is delivered by trained midwives, psychologists, and mental health nurses, through interactive workshops and supportive group activities.

Behavioral: Psychological Empowerment Program

Control Group

NO INTERVENTION

Participants assigned to the control group will receive routine antenatal and postnatal care provided by the healthcare facility, including standard health education and pregnancy monitoring, without the structured psychological empowerment intervention.

Interventions

The Psychological Empowerment Program is a theory-based behavioura intervention designed for pregnant women to prevent postpartum depression. The intervention is based on Zimmerman's Psychological Empowerment Theory and focuses on strengthening perceived control, self-efficacy, and coping behaviour during pregnancy and the transition to motherhood. The program consists of 5 structured sessions conducted in 3 weeks a, each lasting approximately 90 minutes. Sessions are delivered in small groups (12 participants each group) through interactive workshops, guided discussions, role-play activities, coping skills training, communication exercises, problem-solving simulations, and reflective journaling. The intervention includes psychoeducation on postpartum depression, stress management techniques, emotional regulation strategies, assertive communication training, and practical preparation for parenting challenges.

Also known as: PEP
Intervention Group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsParticipant must be a pregant women who expected first child with a gestational age range of 30-33 weeks
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women between 30-33 weeks of gestation
  • Primiparous
  • Age 18 years and above
  • Able to read and communicate in the local language
  • Living with a partner

You may not qualify if:

  • History of diagnosed psychiatric illness (e.g., bipolar disorder, schizophrenia)
  • High-risk pregnancy conditions that require specialized medical care
  • Unwilling or unable to commit to the intervention schedule

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Primary Health Centre Lubuk Begalung

Padang, West Sumatra, 25163, Indonesia

Location

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Yu Ying Lu, Professor

    National Taipei University of Nursing and Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Doctoral Researcher

Study Record Dates

First Submitted

May 28, 2026

First Posted

June 9, 2026

Study Start

March 10, 2026

Primary Completion (Estimated)

August 25, 2026

Study Completion (Estimated)

August 30, 2026

Last Updated

June 9, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication will be shared. The shared datasets may include participant demographic characteristics, baseline measures, intervention allocation, and outcome data collected at all study time points, including scores on the Edinburgh Postnatal Depression Scale (EPDS), the General Self-Efficacy Scale (GSES), the Pearlin Mastery Scale, and the Brief COPE Inventory. Data will be provided in a de-identified format to protect participant confidentiality.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
De-identified individual participant data (IPD) and supporting documentation will be available beginning 6 months after publication of the primary study results and will remain available for 5 years following publication.
Access Criteria
Data will be available to qualified researchers who provide a methodologically sound research proposal. Requests will be reviewed by the principal investigator. Data will be shared after approval of a data use agreement designed to protect participant confidentiality.

Locations